Mylan has announced that it is voluntarily recalling 15 lots of products containing valsartan because of the detection of trace amounts of N-nitrosodiethylamine within the active ingredient, according to a company announcement posted on the website of the Food and Drug Administration. Consumers who have the recalled product and have questions can call 1-888-406-9305 (Monday through Friday, 8 a.m. to 5 p.m. Eastern time).Be in the know. Mylan Expands its Voluntary Nationwide Recall of Valsartan Tablets, USP, Amlodipine and Valsartan Tablets, USP, and Valsartan and Hydrochlorothiazide Tablets, USP, to All Lots Within Expiry Due to the Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Found in the Active Pharmaceutical IngredientFor further information: Christine Waller (Media), 724.514.1968, or Melissa Trombetta (Investors), 724.514.1813 Out of an abundance of caution, these products are being recalled due to detected trace amounts of an impurity, N-nitrosodiethylamine (NDEA) contained in the API Valsartan, USP, manufactured by Mylan Laboratories Limited. Ambassador to China Terry Branstad is stepping downPutin critic continues to recover as evidence mounts against RussiaBattleground Tracker: Latest polls, state of the race and more5 things to know about CBS News' 2020 Battleground TrackerRepublicans see U.S. as better off now than 4 years ago: CBS News pollWith more mail-in ballots, officials urge patience on election nightAmericans and the right to vote: Why it's not easy for everyoneDemocrats are happy with Biden's VP pick: CBS News pollWhy some mail-in ballots are rejected and how to make sure your vote countsWhat happens if the president doesn't accept the election results?Election Day could turn into "Election Week" with rise in mail ballots Wholesalers, retailers and consumers that are in possession of recalled product should contact Stericycle at 1-888-406-9305 for the return of the recalled product. Mylan Wholesalers, retailers and consumers that are in possession of recalled product should contact Stericycle at 1-888-406-9305 for the return of the recalled product. By clicking Continue below you are leaving Mylan.com and going to a third-party site. Mylan Mylan Normal business hours are Monday through Friday, 8 a.m. to 5 p.m. EST, according to the statement. Update [12/6/2018] Mylan Pharmaceuticals is expanding its voluntary recall to include all lots of non-expired valsartan-containing products due to trace amounts of N-Nitrosodiethylamine (NDEA) in the valsartan active pharmaceutical ingredient (API) manufactured by Mylan Laboratories Limited. Patients should contact their pharmacist or physician who can advise them about an alternative treatment prior to returning their medication. The most recent update in this recall involves the fact that Teva Pharmaceuticals has initiated a voluntary recall of all lots of valsartan-containing products that have been made with the active pharmaceutical ingredient (API) from Mylan Pharmaceuticals. These batches were distributed in the U.S. between March 2017 and November 2018. NDEA is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen according to the International Agency for Research on Cancer (IARC).The finished products are manufactured by Mylan Pharmaceuticals Inc. and Mylan Laboratories Limited. Update [12/6/2018] Mylan Pharmaceuticals is expanding its voluntary recall to include all lots of non-expired valsartan-containing products due to trace amounts of N-Nitrosodiethylamine (NDEA) in the valsartan active pharmaceutical ingredient (API) manufactured by Mylan Laboratories Limited. FDA does not endorse either the product or the company.Out of an abundance of caution, these products are being recalled due to detected trace amounts of an impurity, N-nitrosodiethylamine (NDEA) contained in the API Valsartan, USP, manufactured by Mylan Laboratories Limited. Mylan The 104 additional lots include 26 lots of Amlodipine and Valsartan Tablets, USP (including the … Mylan The Food and Drug Administration this month warned Mylan over manufacturing shortcomings the regulator found at an Indian plant producing the blood pressure medicine valsartan. Normal business hours are Monday through Friday Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to using these drug products.This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.